More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.
Rare Disease Genetic Testing: Introduction
- More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.
- Genetic testing is an advanced diagnostic tool that not only helps to identify the exact disease manifestations but also determine the underlying causes of genetic disorders
- Genetic testing offers various benefits including confirming a diagnosis, understanding the cause of unexplained symptoms, and identifying treatment options including clinical trials
Read Report Overview - https://www.transparencymarketresearch.com/rare-disease-genetic-testing-market.html
Key Drivers and Restraints of Global Rare Disease Genetic Testing Market
- Growth of molecular biology has transformed the diagnosis and treatment of diseases. Modern test methods, based on the detection of DNA and RNA, offer several advantages over traditional methods for the detection of diseases. New procedures can detect viruses, bacteria, and genetic variations faster and much more accurately.
- New innovative technologies such as RT-PCR and sequencing are available in the market, which provide a comparatively less expensive method of diagnosis, prognosis, and therapy selection in patients throughout their treatment plan. This helps physicians to frame appropriate therapeutic regimes for patients suffering from disease.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_80353
- Thus, continuous improvement in the technology is expected to drive the global rare disease genetic testing market during the forecast period
- Prevalence of autoimmune disease throughout modern societies has been increasing at a steady pace for the last few decades
- According to Autoimmunity Reviews, autoimmune diseases are a leading cause of death in the U.S. among young and middle aged people
- For instance, according to International Journal of Recent Scientific Research, the incidence of celiac diseases has increased in countries such as Scotland and Canada in the last 60 years
- Thus an increase in the incidence of these diseases is a key factor that is estimated to propel the global rare disease genetic testing market during the forecast period
Request for Analysis of COVID-19 Impact on Rare Disease Genetic Testing Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_80353
Next-generation Sequencing to Offer Lucrative Growth Opportunities
- The global rare disease genetic testing market can be segmented based on technology, specialty, indication, end-user, and region
- In terms of technology, the global rare disease genetic testing market can be classified into next generation sequencing (whole exome sequencing and whole genome sequencing), array technology, PCR - based testing, FISH, sanger sequencing, and karyotyping
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_80353
- Based on specialty, the market can be segmented into molecular genetic tests, chromosomal genetic tests, and biochemical genetic tests. In terms of indication, the global rare disease genetic testing market can be segmented into neurological disorders, immunological disorders, hematology diseases, endocrine & metabolism diseases, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology diseases, and other rare diseases.
- Based on end-user, the global market can be categorized into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories
Pre Book Rare Disease Genetic Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_80353<ype=S
North America & Europe to Dominate Rare Disease Genetic Testing Market
- The global rare disease genetic testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- High prevalence of different types of cancer and rising geriatric population in the region are some factors augmenting the market in North America. Rise in awareness regarding disease prevention and increasing adoption of advanced technological platforms for the development of various diagnostic tests are some factors boosting the market in Europe.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/